| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Biomarin Pharmaceutical Inc(BMRN) | 177,741 | $15.7M | 25.62% |
| 2 | Abbvie Inc(ABBV) | 94,448 | $12.8M | 20.86% |
| 3 | Centene Corp(CNC) | 148,254 | $12.2M | 19.93% |
| 4 | Cytokinetics Inc(CYTK) | 225,032 | $10.3M | 16.74% |
| 5 | Argenx SE(ARGX) | 20,881 | $7.3M | 11.93% |
| 6 | Aclaris Therapeutics Inc(ACRS) | 198,493 | $2.9M | 4.71% |
| 7 | Horizon Therapeutics PLC | 137,610 | $14.8K | 0.02% |
| 8 | Unitedhealth Group Inc(UNH) | 26,844 | $13.5K | 0.02% |
| 9 | Iqvia Holdings Inc(IQV) | 44,314 | $12.5K | 0.02% |
| 10 | Bellus Health Inc(BLU) | 1,280,757 | $10.3K | 0.02% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 99.46% | 99.92% | +0.46% |
| Unclassified | 0.54% | 0.08% | -0.46% |
Quarter-over-quarter weight changes by market cap
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Large Cap | 0.16% | 57.52% | +57.36% |
| Mega Cap | 0.05% | 20.9% | +20.85% |
| Mid Cap | 66.43% | 16.76% | -49.67% |
| Small Cap | 32.72% | 4.72% | -28% |
| Unclassified | 0.54% | 0.08% | -0.46% |
| Micro Cap | 0.11% | 0.01% | -0.1% |
Quarter-over-quarter position changes